US states say Sandoz must face antitrust claims in generic drugs case
MLex Summary: US states opposed Sandoz’s motion for summary judgment in a US case over generic drug pricing, saying it creates a straw-man version of the alleged overarching conspiracy that is...To view the full article, register now.
Already a subscriber? Click here to view full article